1. The terminal complement complex C5b-9, but not the anaphylatoxin C5a, is cross-sectionally associated with fatty liver disease: the codam study. Issue 1 (July 2015) Authors: van Greevenbroek, M.; Wilbrink, M.; Hertle, E.; Wlazlo, N.; van der Kallen, C.; Feskens, E.; Schalkwijk, C.; Stehouwer, C. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗